Shilpa Medicare has effectively finished its phase 1 clinical trial for its leading product, sRbumin, a recombinant human albumin 20% (rHA). Human serum albumin is crucial for different medical interventions, including fluid replacement therapy...
On Tuesday, Bharat Biotech announced that its oral cholera vaccine has successfully completed a late-stage trial and is preparing for a global launch, with plans to produce up to 200 million doses annually. The vaccine, named Hillchol, has receive...
Alkermes plc has commenced the Vibrance-2 study, which is a phase 2 clinical trial assessing the safety and effectiveness of ALKS 2680 versus placebo in adult patients with narcolepsy type 2 (NT2). ALKS 2680 is a new, under investigation, oral...
Vimgreen Pharmaceuticals, a research-based pharmaceutical company specializing in adenosine signaling modulation, shared that they have finished enrolling participants in a phase 2 clinical trial for VG081821AC, a new drug for early-to-mid stage...
Biosyngen, a company focused on immuno-oncology, stated that its EBV-specific CAR-T cell therapy, BRG01, has received approval from the US Food and Drug Administration (FDA) to advance into a crucial phase II clinical trial. This is the initial...
, CDSCO.jpg)
